TED 2017_10 CNCD vs Yerko Bravo Rojas

In October 2016 the National Doping Control Commission of Chile (CNCD) has reported an anti-doping rule violation against the boxer Yerko Bravo Rojas after his sample tested positive for the prohibited substance Stanozolol.

After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Disciplinary Panel of the Tribunal de Expertos en Dopaje (TED).

The Athlete denied the intentional use of the substance and explained that due to his work he suffered from a chronic back injury and despite medical treatments he did not recover. Recommended by a friend at the gym as treatment he was was injected with a medication while he was unaware that this was a prohibited substance. He asserted that in his personal circumstances he was less aware of prohibited substances.

The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation.

The Panel considers the Athlete's personal circumstances in this case and accepts that the substance was not used intentional with grounds for a reduced sanction.

Therefore the TED Disciplinary Panel decides on 10 April 2017 to impose 10 month period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 11 October 2016.

Original document

Parameters

Legal Source
National Decisions
Date
10 April 2017
Arbitrator
Glucksmann Meissner, Roberto
Ramírez Tagle, Cristián
Wigg Sotomayor, María Isabel
Original Source
Government of Chile
Country
Chile
Language
Spanish
ADRV
Adverse Analytical Finding / presence
Legal Terms
Circumstantial evidence
No intention to enhance performance
No Significant Fault or Negligence
Period of ineligibility
Sport/IFs
Boxing (IBA) - International Boxing Association
Other organisations
Comisión Nacional de Control de Dopaje de Chile (CNCD) - National Doping Control Commission of Chile
TED - Tribunal de Expertos en Dopaje
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S1. Anabolic Agents
Substances
Stanozolol
Medical terms
Physical injury
Treatment / self-medication
Document type
Pdf file
Date generated
7 July 2022
Date of last modification
26 July 2022
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin